Development of a CRISPR/Cas-Based Detection Platform for Tracking Decreased Susceptibility to Cephalosporins in Neisseria gonorrheae حسب Ziyuan Zhao (2889005)

"…Developing efficient and accurate detection of resistant strains is urgently needed for their management and treatment. We have developed the Multiplex Integrated RPA-CRISPR/Cas12a detection Assay (MIRCA) for simultaneous detection of Neisseria gonorrheae (<i>Ng</i>) and mutations with decreased susceptibility to cephalosporins. …"

GLM models for predictors of monthly HIV costs. حسب Drew B. Cameron (10687420)

"…The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. This study aims to build evidence on the burden of current out-of-pocket costs of care among HIV-HTN co-morbid patients.…"

Median cost (USD) per visit breakdown. حسب Drew B. Cameron (10687420)

"…The integration of care for these conditions presents an opportunity to achieve efficiencies in delivery as well as decrease overall costs for patients. This study aims to build evidence on the burden of current out-of-pocket costs of care among HIV-HTN co-morbid patients.…"

Probability of Cost-Effectiveness Across CET. حسب Yiping An (20609789)

"…Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…"

Advancing Circular Bioeconomy through a Systems-Level Assessment of Food Waste and Industrial Sludge Codigestion حسب Md. Nizam Uddin (21632518)

"…The sustainability analysis revealed that the codigestion of FW-PPMS had median costs of 236.64 USD·tonne^–1·day^–1 and emissions of 228.30 kg CO₂ eq·tonne^–1·day^–1, a significant reduction compared to directly disposing the FW in landfills (median costs of 405.13 USD·tonne^–1·day^–1 and emissions of 556.27 kg CO₂ eq·tonne^–1·day^–1). …"

Bivariate analysis results. حسب Oejin Shin (20855617)

"…<div><p>Older adults often face financial difficulties due to declining physical and cognitive abilities, and rising healthcare costs exacerbate these issues. Despite a general decrease in poverty, the rate among those aged 65 and older has increased. …"

Sequence analysis results. حسب Oejin Shin (20855617)

"…<div><p>Older adults often face financial difficulties due to declining physical and cognitive abilities, and rising healthcare costs exacerbate these issues. Despite a general decrease in poverty, the rate among those aged 65 and older has increased. …"

Descriptive analysis. حسب Oejin Shin (20855617)

"…<div><p>Older adults often face financial difficulties due to declining physical and cognitive abilities, and rising healthcare costs exacerbate these issues. Despite a general decrease in poverty, the rate among those aged 65 and older has increased. …"

Variables name and variable measurement. حسب Jinyuan Li (5927267)

"…Using the medical insurance records from 2017 to 2022, we evaluated the impact of the DRG system on medical costs, service efficiency and healthcare quality.…"

Cascade of care by HCV testing model. حسب Bao Vu Ngoc (14551955)

"…HCVST was still costlier at CBOs but cheaper at clinics compared to standard testing when kit costs decreased to $2 ($417 vs. $218 and $357 vs. $408). …"

Factors associated with first-time HCV testing. حسب Bao Vu Ngoc (14551955)

"…HCVST was still costlier at CBOs but cheaper at clinics compared to standard testing when kit costs decreased to $2 ($417 vs. $218 and $357 vs. $408). …"

Study Flowchart. حسب Jae-Heung Cho (798319)

"…When a “willingness to pay for treatment ($26,375)” threshold was applied, the probability of CMT being cost-effective was 68.1%–98.3%. Despite no significant differences in pain reduction at week 5, CMT was found to be a cost-effective treatment for TMD, particularly for improving function and quality of life. …"

Changes in outcomes over time. حسب Jae-Heung Cho (798319)

"…When a “willingness to pay for treatment ($26,375)” threshold was applied, the probability of CMT being cost-effective was 68.1%–98.3%. Despite no significant differences in pain reduction at week 5, CMT was found to be a cost-effective treatment for TMD, particularly for improving function and quality of life. …"

Study timetable. حسب Jae-Heung Cho (798319)

"…When a “willingness to pay for treatment ($26,375)” threshold was applied, the probability of CMT being cost-effective was 68.1%–98.3%. Despite no significant differences in pain reduction at week 5, CMT was found to be a cost-effective treatment for TMD, particularly for improving function and quality of life. …"

Cumulative incidence curves of recovery by group. حسب Jae-Heung Cho (798319)

"…When a “willingness to pay for treatment ($26,375)” threshold was applied, the probability of CMT being cost-effective was 68.1%–98.3%. Despite no significant differences in pain reduction at week 5, CMT was found to be a cost-effective treatment for TMD, particularly for improving function and quality of life. …"

Cost analysis of irrigation controller unit. حسب Gourab Saha (8987405)

Estimating the transportation cost matrix from microstate joint probability of consecutive timesteps at rest. حسب Giacomo Barzon (19832364)

Base-case analysis. حسب Yiping An (20609789)

"…Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…"

Study data. حسب Jie Liu (15128)

"…The Morisky score of the roxadustat group was higher [7 (5, 8) vs. 6 (4, 8), <i>P</i> < 0.01]. The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. …"

Summary of clinical outcomes after 9 months. حسب Jie Liu (15128)

"…The Morisky score of the roxadustat group was higher [7 (5, 8) vs. 6 (4, 8), <i>P</i> < 0.01]. The drug cost of the roxadustat group was higher, but another additional cost for correcting anemia was significantly reduced. …"